Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederglobenewswire.com
GlobeNewswire - Industry News on Biotechnology
Get the latest updates from GlobeNewswire - Industry News on Biotechnology directly as they happen.
Follow now 88 followers
Latest posts
Last updated about 9 hours ago
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy
about 9 hours ago
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in...
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
about 9 hours ago
Scribe Therapeutics announces closing of initial public offering
ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease
about 9 hours ago
Cambridge, Massachusetts, July 27, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq...
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
about 9 hours ago
RADNOR, Pa., July 27, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq...
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
about 9 hours ago
SOUTH SAN FRANCISCO, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics...
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
about 9 hours ago
Dr. Rooney, former immunology leader at Johnson & Johnson, will lead clinical...
Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel
about 14 hours ago
SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR)...
Applied Biologics Announces Extension of Longstanding System-Wide Agreement With Providence Health & Services for XWRAP®
about 15 hours ago
Applied Biologics extends longstanding system-wide agreement with Providence Health & Services for...
Revagenix Doses First Participant in Phase 1 Trial of Rev-56, an Inhaled Therapy for Non-CF Bronchiectasis
about 16 hours ago
Revagenix has dosed the first participant in the Phase 1 clinical trial...
NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million
about 17 hours ago
Follow-on investment would increase NewGen’s aggregate ownership to 13% Follow-on investment would...
Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement
about 17 hours ago
The offering is led by existing investor BVF Partners L.P.
Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome
about 17 hours ago
SKNJCT-005 registrational clinical study protocol strengthened through planned implementation of FDA recommendations...